Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tamibarotene in Amyotrophic Lateral Sclerosis
NCT00886977Phase 2Unknown
- Sponsor
- Yoshino Neurology Clinic
- Start
- Apr 2009
- Primary completion
- Dec 2010
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of tamibarotene in amyotrophic lateral sclerosis (ALS), sponsored by Yoshino Neurology Clinic. Status: unknown.
02
Drugs
tamibarotene
03
Conditions
amyotrophic lateral sclerosis (ALS)
Beyond the preview
Go deeper on NCT00886977.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00886977.